157 related articles for article (PubMed ID: 15770879)
1. Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure.
Rodríguez-Reyna TS; Arrieta O; Castillo-Martínez L; Orea-Tejeda A; Guevara P; Rebollar V; Granados J
Clin Invest Med; 2005 Feb; 28(1):23-9. PubMed ID: 15770879
[TBL] [Abstract][Full Text] [Related]
2. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
[TBL] [Abstract][Full Text] [Related]
3. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
4. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
5. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
[TBL] [Abstract][Full Text] [Related]
7. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure.
Perna ER; Macín SM; Cimbaro Canella JP; Alvarenga PM; Pantich RE; Ríos NG; Cialzeta JR; Farías EF; Badaracco JR; Brizuela M; Jantus E; Missov ED
Med Sci Monit; 2004 Mar; 10(3):CR90-5. PubMed ID: 14976458
[TBL] [Abstract][Full Text] [Related]
8. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
9. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
Lubrano V; Pingitore A; Carpi A; Iervasi G
Biomed Pharmacother; 2010 Mar; 64(3):165-9. PubMed ID: 19926244
[TBL] [Abstract][Full Text] [Related]
10. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.
Perna ER; Macin SM; Canella JP; Augier N; Stival JL; Cialzeta JR; Pitzus AE; Garcia EH; Obregón R; Brizuela M; Barbagelata A
Circulation; 2004 Oct; 110(16):2376-82. PubMed ID: 15477403
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).
Torre-Amione G; Kapadia S; Benedict C; Oral H; Young JB; Mann DL
J Am Coll Cardiol; 1996 Apr; 27(5):1201-6. PubMed ID: 8609343
[TBL] [Abstract][Full Text] [Related]
12. Prognostic use of cardiac troponin T and troponin I in patients with heart failure.
Healey JS; Davies RF; Smith SJ; Davies RA; Ooi DS
Can J Cardiol; 2003 Mar; 19(4):383-6. PubMed ID: 12704483
[TBL] [Abstract][Full Text] [Related]
13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
14. The pro-apoptotic serum activity is an independent mortality predictor of patients with heart failure.
Rössig L; Fichtlscherer S; Heeschen C; Berger J; Dimmeler S; Zeiher AM
Eur Heart J; 2004 Sep; 25(18):1620-5. PubMed ID: 15351161
[TBL] [Abstract][Full Text] [Related]
15. Triiodothyronine levels for risk stratification of patients with chronic heart failure.
Pingitore A; Landi P; Taddei MC; Ripoli A; L'Abbate A; Iervasi G
Am J Med; 2005 Feb; 118(2):132-6. PubMed ID: 15694896
[TBL] [Abstract][Full Text] [Related]
16. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
[TBL] [Abstract][Full Text] [Related]
17. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
18. Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis.
Kell R; Haunstetter A; Dengler TJ; Zugck C; Kübler W; Haass M
Eur Heart J; 2002 Jan; 23(1):70-8. PubMed ID: 11741364
[TBL] [Abstract][Full Text] [Related]
19. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
[TBL] [Abstract][Full Text] [Related]
20. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
